Studies on the mechanism of action of the tumour inhibitory triazenes.
D000477:Alkylating Agents / Q000627:therapeutic use; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003640:Dealkylation; D007930:Leucine / Q000378:metabolism; D008223:Lymphoma / Q000188:drug therapy; D051379:Mice; D008807:Mice, Inbred BALB C; D008815:Mice, Inbred Strains; D008861:Microsomes / Q000378:metabolism; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000188:drug therapy; D009607:Nitrosourea Compounds / Q000627:therapeutic use; D010954:Plasmacytoma / Q000188:drug therapy*; D010984:Platinum / Q000627:therapeutic use; D013936:Thymidine / Q000378:metabolism; D013997:Time Factors; D014184:Transplantation, Homologous; D014226:Triazenes / Q000008:administration & dosage / Q000627:therapeutic use*; D014316:Tritium; D014529:Uridine / Q000378:metabolism
D000477:Alkylating Agents; D000970:Antineoplastic Agents; D009607:Nitrosourea Compounds; D014226:Triazenes; D014316:Tritium; D010984:Platinum; D007930:Leucine; D013936:Thymidine; D014529:Uridine